Background and Purpose-Endovascular therapy is increasingly used in acute ischemic stroke treatment and is now considered the gold standard approach for selected patient populations. Prior studies have demonstrated that eventual patient outcomes depend on both patient-specific factors and procedural considerations. However, these factors remain unclear for acute basilar artery occlusion stroke. We sought to determine prognostic factors of good outcome in acute posterior circulation large vessel occlusion strokes treated with endovascular therapy. Methods-We reviewed our prospectively collected endovascular databases at 2 US tertiary care academic institutions for patients with acute posterior circulation strokes from September 2005 to September 2015 who had 3-month modified Rankin Scale documented. Baseline characteristics, procedural data, and outcomes were evaluated. A good outcome was defined as a 90-day modified Rankin Scale score of 0 to 2. The association between clinical and procedural parameters and functional outcome was assessed. Results-A total of 214 patients qualified for the study. Smoking status, creatinine levels, baseline National Institutes of Health Stroke Scale score, anesthesia modality (conscious sedation versus general anesthesia), procedural length, and reperfusion status were significantly associated with good outcomes in the univariate analysis. Multivariate logistic regression indicated that only smoking (odds ratio=2.61; 95% confidence interval, 1.23-5.56; P=0.013), low baseline National Institutes of Health Stroke Scale score (odds ratio=1.09; 95% confidence interval, 1.04-1.13; P<0.0001), and successful reperfusion status (odds ratio=10.80; 95% confidence interval, 1.36-85.96; P=0.025) were associated with good outcome. Conclusions-In our retrospective case series, only smoking, low baseline National Institutes of Health Stroke Scale score, and successful reperfusion status were associated with good outcome in patients with posterior circulation stroke treated with endovascular therapy.
V ertebrobasilar occlusion strokes (VBOS) are rare, represent only 1% of all ischemic strokes and 5% of large vessel occlusion strokes, 1, 2 and are devastating because the rate of poor outcomes in the VBOS population remains high (80%) despite recent advances in stroke care. 3, 4 Treatment options include intravenous and intra-arterial thrombolysis and mechanical thrombectomy, with mixed results. 1 A metaanalysis of 5 recent landmark endovascular therapy (ET) trials has confirmed the superiority of mechanical thrombectomy in large vessel occlusion for acute anterior circulation strokes presenting early in the therapeutic window 5 and led to the change in the American Heart Association guidelines such that ET should be considered reasonable for select patients with VBOS (Class IIb; Level of Evidence C) 6 although all the aforementioned trials excluded patients with VBOS. Prior ET studies in patients with anterior circulation, large vessel occlusion have demonstrated patient outcome depends on patient-specific factors and procedural considerations. 7 However, in acute basilar artery occlusion strokes, those factors remain elusive. A better understanding of the relevant factors that affect outcome will help inform therapeutic strategies for this patient population.
We sought to describe our experience with ET for VBOS at 2 large tertiary care centers, assess its feasibility and safety, and evaluate prognostic parameters associated with favorable clinical outcomes.
Methods

Patient Selection
We reviewed prospectively collected registries of consecutive VBOS (basilar artery occlusions or rare bilateral vertebral occlusions [functional basilar occlusions]) treated with ET from 2 US tertiary care academic institutions (from September 2010 to September 2015 in institution no. 1 and September 2005 to September 2015 in institution no. 2). Patients with missing 3-month modified Rankin Scale (mRS) data were excluded. Institutional imaging protocols included noncontrast computed tomography (CT), CT angiography±CT perfusion at institution no. 1. At institution no. 2, most cases underwent noncontrast CT and CT angiography imaging. In rare occasions, only noncontrast CT for patients presenting early in the therapeutic window and showing a hyperdense sign and MRI/magnetic resonance angiography for those presenting late in the therapeutic window. Imaging modalities selection relied on physician preferences and the logistics at each center.
Parameter Definitions
Time of stroke onset was recorded if witnessed or time from last known normal if the exact time was not known. In some cases, both times could not be assessed and were categorized as unknown. Time from last known normal to puncture was further categorized into subgroups as follows: 0 to 6 hours, 6 to 12 hours, 12 to 24 hours, and >24 hours for further analysis.
Baseline stroke severity was assessed by the National Institutes of Health Stroke Scale (NIHSS) score at initial presentation and was categorized into subgroups: <10, 10 to 20, and >20.
The anesthesia modality was categorized as follows: (1) general anesthesia that included those intubated before the procedure and those electively intubated for the procedure, and (2) monitored anesthesia care that included those converted to general anesthesia during the procedure. The anesthesia protocol was comparable across both centers. Essentially, monitored anesthesia care was performed with a dexmedetomidine infusion with supplemental fentanyl and midazolam as needed. For patients requiring general anesthesia, induction was achieved with propofol and a paralytic agent (succinylcholine or rocuronium). Anesthesia was then maintained with volatile anesthetics (sevoflurane, isoflurane, or desflorane) along with fentanyl or remifentanil. Further paralytics were typically avoided but were used for a subset of patients and monitored by qualitative trainof-4 measurements. Additional agents used included ondansetron (as needed) and phenylephrine (to maintain systolic blood pressure above or within 20% of the patient's presenting pressure). 8 The primary outcome was the proportion of patients with good clinical outcome at 90 days. Good outcome was defined as mRS score of 0, 1, or 2. Ambulatory outcome was defined as an mRS score of 0 to 3.
Secondary end points included the rates of successful reperfusion (modified Thrombolysis in Cerebral Infarction 2b-3). 9 Safety end points were 90-day mortality and rates of any parenchymal hematoma as defined in the European Cooperative Acute Stroke Study. 10 This study was approved by each local institutional review board. 
Statistical Analysis
Results
A total of 215 patients with VBOS were treated with ET during the study period. One patient had an incomplete outcome data set and was excluded, thus, 214 underwent primary analysis. Mean age was 64.3±13.5 years with median admission NIHSS score of 21 interquartile range (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) . Baseline characteristics, procedural and outcome parameters are summarized in Table 1 . Median time from last known normal to puncture was 621 minutes interquartile range (285-1120). In terms of procedural characteristics, stent retrievers were more frequently used (37.8%) then intraarterial thrombolysis (32.2%), intracranial stenting (28%), Merci retrievers (21.5%), and thromboaspiration (20.6%). Monitored anesthesia care was used in 29% of the cases, and median procedure length was 90 minutes interquartile range (62-132). Successful reperfusion (modified Thrombolysis in Cerebral Infarction 2b-3) was achieved in 190 (87.6%) cases. Parenchymal hematomas occurred in 23 (10.8%) patients. Ninety-day good and ambulatory outcomes were achieved in 58 (26.6%) and 82 (37.8%) patients, respectively, while mortality rate was 46.7%. (Figure 1) .
Results from univariate analyses are shown in Table 1 Figure 2 ). Shorter procedural length (P=0.02), monitored anesthesia care (P=0.007), and successful reperfusion (P=0.006) were associated with good outcomes at 90 days. Time from last known normal to puncture, used as a continuous or categorical variable, was not associated with good outcome (Figure 2 ). There was also a statistically significant difference in 90-day mortality rates between modified Thrombolysis in Cerebral Infarction 2b-3 patients and those that did not achieve successful reperfusion (41.4% versus 85.2%; P<0.001).
Stent retrievers were more often used after 2010 (53.9% versus 0%; P<0.01) while IA tPA (intra-arterial tissue-type plasminogen activator) and Merci retrievers were more often used early in the study period (61.3% versus 20.5%; P≤0.01 and 51.6% versus 9.3%; P<0.01, respectively). However, there were no statistically significant differences in rates of successful reperfusion (P=0.16) and good outcomes (P=0.4) between the 2 time periods (ie, 2005-2010 and 2011-2015) .
In multivariable analysis, only smoking (odds ratio=2.61; 95% confidence interval, 1.23-5.56; P=0.013), low baseline NIHSS (odds ratio=1.09; 95% confidence interval, 1.04-1.13; P<0.0001), and reperfusion status (odds ratio=10.80; 95% confidence interval, 1.36-85.96; P=0.025) were associated with good outcome at 90 days (Table 2 ).
Discussion
Our study shows a strong correlation between reperfusion and outcome in patients with VBOS treated with ET with a 10-fold increase in the likelihood of achieving good functional outcomes if successful reperfusion is attained and twice as high mortality rates in nonrecanalized patients. Our series represents the largest series to date of VBOS treated with ET. It is also the most inclusive and diverse analysis in regards to stroke severity, time to treatment, and techniques and devices used, thus representing an extensive experience with ET for this patient population.
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December 2017 We observed a good outcome in 26.6% of the patients and ambulatory outcome in 37.7% as compared with 46% and 56.9% in the recently published HERMES meta-analysis (Highly Effective Reperfusion Evaluated in Multiple Endovascular Stroke Trials) of ET for anterior circulation strokes. 5 Although these proportions may seem relatively low compared with anterior circulation strokes, our patients had more severe stroke deficits with 25% having an NIHSS >28 and 26% (n=39) of them required intubation before angiosuite arrival. Moreover, given the documented poor natural history of VBOS with 80% of patients having dismal outcomes, 3, 4 and the fact that more than half of the patients included in our analysis presented late in the therapeutic window, our observed mRS 0 to 2 rates become relatively favorable.
We report similar rates of successful reperfusion for VBOS (88%) regardless of procedural factors (ie, inclusion of older devices and techniques) as compared with previously published studies where rates were between 78% and 89%. 3, [11] [12] [13] [14] This rate was also higher than what was observed in the HERMES meta-analysis (71%) despite the wide use of stent retrievers in the latter (proven to be superior to first generation devices). 5 As previously reported, 11 we also demonstrate a strong association between recanalization and good clinical outcomes. Indeed, we show a 10-fold increase in the odds of attaining good outcomes if successful reperfusion is achieved. Similarly, mortality rates were twice as high in the group where recanalization could not be achieved. However, successfully reperfused patients do not consistently achieve good outcome, and this could be explained by differences in admission variables and extent of established infarction especially in the brain stem. 15, 16 In fact, Greving et al 15 studied predictors of clinical outcome after medically treated basilar artery stroke and demonstrated that good outcomes could be reliably predicted by a simple model, including older age, absence of hyperlipidemia, presence of prodromal minor stroke, higher baseline NIHSS score, and longer time to treatment. Two of the key findings of this study that seem to contradict the aforementioned model are that age and time of treatment did not predict clinical outcomes. Historically, age is known to be a predictor of outcome in stroke regardless of location. 3, 5, 11, 17, 18 However, in our series, patients who achieved good outcomes were chronologically younger in univariate analysis. After adjustment for potential confounders, age was not significantly associated with good functional outcomes. This might be because of a selection bias during treatment decision. Although our findings challenge those of the BASICS (Basilar Artery International Cooperation Study), 3 they confirm the ENDOSTROKE (Endovascular Stroke Treatment) registry 12 data, the largest series of posterior circulation strokes treated with ET, and the recently published Mokin et al 13 series, and suggest that if properly selected, older patients may still benefit from ET.
Time to presentation has been widely described as having a robust impact on outcomes and current guidelines recommend offering ET to patients presenting within 6 hours of stroke onset. The BASICS study reported a decrease in good outcomes with longer times from onset to treatment. 3 This could be explained by the fact that they included large infarcts meaning patients with poor collateral patterns where time is known to be a less important prognostic factor. 19 In a recently published medical hypothesis paper, Lindsberg et al 20 hypothesize that distinct features of the posterior circulation, such as highly developed, persistent collateral arterial network, reverse filling of the distal basilar artery, and delicate plasma flow siding the clot, might sustain patency of brain stem perforators and thus slow the tissue necrosis clock rendering recanalization at any time during that time period efficient.
Similar to the BASICS analysis, Mokin et al 13 demonstrated in a series of 100 patients with posterior circulation that a time to recanalization ≤6 hours was highly associated with good outcomes. In the ENDOSTROKE registry, 12 although not significant, there was a trend toward worse outcomes in those presenting after 9 hours from stroke onset. At our institutions, because of the poor prognosis of VBOS, it has been common practice to treat patients outside the traditional 6-hour window where a chance of meaningful recovery was considered reasonable. Selection was left to the treating team's discretion and was based on demographic, clinical, and imaging parameters. We demonstrate in our series that time of presentation is not associated with outcomes and that even patients presenting beyond 12 or 24 hours may still benefit from ET. Our findings are in accordance with those of Strbian et al, 21 who showed in a series of 184 patients with basilar artery occlusions that in the absence of extensive baseline ischemia, recanalization of BAO up to 48 hours was rarely futile and produced good outcomes in 50% of cases, independent of time to treatment. 21 Another noteworthy finding is the association between smoking and favorable clinical outcomes. In the past decade, several studies have investigated this so-called smoking-thrombolysis paradox with mixed results. [22] [23] [24] [25] In a recent analysis of 968 patients who underwent ET for large vessel occlusion strokes, we found that smoking was not associated with clinical outcomes regardless of stroke location (anterior versus posterior) or pathogenesis. 25 Moreover, we think that the phenomenon is probably because of a selection bias. 24 Indeed, when we looked at the entire distribution of 90-day mRS in our study population (versus dichotomized outcome), the impact of smoking on clinical outcomes was no longer statistically significant.
Our study has several limitations mostly inherent to its retrospective design and variations in treatment protocols and patient selection paradigms at the 2 participating centers. We also did not have a control group of patients who did not undergo intervention and that would have allowed us to measure treatment effects. In addition, we also did not investigate baseline cerebral tissue imaging parameters and their correlations with outcomes because the use of advanced imaging modalities, such as CT angiography and CT perfusion, was inconsistent and relied on physician preferences and the logistics at each center. These may have potentially confounded our results. However, our study represents the largest series of ET-treated VBOS to the best of our knowledge to date. The wide inclusion criteria from stroke severity, time of presentation, and the variability in procedural details allow us to improve our understanding of the specific needs of this patient population and the appropriate therapeutic strategies.
Conclusions
In our retrospective case series, only smoking, low baseline NIHSS, and successful reperfusion status were associated with good outcome in patients with posterior circulation stroke treated with ET. 
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